Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy

Condition:

Category: Cancer

Author: Li Zijian

Date: Jun 2018

Type: Article

In this article, they review the pharmacological functions and mechanisms of LDN as well as its clinical therapeutic potential. New discoveries indicate that LDN may become a promising immuno-modulatory agent in the therapy for cancer and many immune-related diseases.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.

>